Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta

Thursday, March 20, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

ATLANTA, March 19 In its ongoing support of the AflacCancer Center and Blood Disorders Service of Children's Healthcare of Atlanta,Aflac announced that it has reached more than $40 million in contributions tothe Center, making it the largest corporate supporter of Children's Healthcareof Atlanta.

"With financial resources provided by Aflac, we have been able to recruitnational leaders in the fields of pediatric cancer, sickle cell disease andexperimental therapy and have also established a thriving program for cancersurvivors," said William G. Woods, M.D., director for the Aflac Cancer Center."These leaders are conducting important lab and clinical research and helpingto bring innovative treatments to patients at the bedside - not just inGeorgia, but nationwide."

Thousands of Aflac field force members across the country and the AflacFoundation together have funded four endowed chairs at the Aflac CancerCenter, each of which provides critical funding in perpetuity for keypositions at the Center. At Children's Healthcare of Atlanta, receiving achair signifies a monetary endowment for a specific program directed by aphysician or researcher. To date, Aflac has funded the following chairs:

Over the years, Aflac's contributions have also been used to fund othercritical needs, including new inpatient and outpatient facilities, a newstate-of-the-art pediatric research building, and endowments for the FamilySupport Team and Fellowship Program.

In addition to the company's donations, both Aflac employees and fieldforce members support patients and their families by volunteering personaltime to play bingo, to take them to Aflac-sponsored events, and to attend theannual Braves Baseball Night with them in Atlanta.

"We became involved with the Aflac Cancer Center and Blood DisordersService at Children's Healthcare of Atlanta more than 13 years ago to helpdiscover treatments and cures for pediatric cancer and blood disorders,"stated Daniel Amos, chairman and chief executive officer of Aflac. "Today, itis recognized as one of the leading pediatric cancer, hematology, and bloodand marrow transplantation programs in the country, treating more than 325 newcancer patients each year and following more than 2,000 patients with sicklecell disease, hemophilia and other blood disorders."

The Aflac Cancer Center and Blood Disorders Service provides advanceddiagnostic and clinical care, as well as innovative treatment and researchoptions to children, adolescents and young adults.

About Aflac

For more than 50 years, Aflac products have given policyholders theopportunity to direct cash where it is needed most when a life-interruptingmedical event causes financial challenges. Aflac is the number one provider ofguaranteed-renewable insurance in the United States and the number oneinsurance company in terms of individual insurance policies in force in Japan.Our insurance products provide protection to more than 40 million peopleworldwide. Aflac has been included in Fortune magazine's listing of America'sMost Admired Companies for seven years and in Fortune magazine's list of the100 Best Companies to Work For in America for ten consecutive years. Aflac hasalso been recognized three times by both Fortune magazine's listing of the Top50 Employers for Minorities and Working Mother magazine's listing of the 100Best Companies for Working Mothers. Aflac Incorporated is a Fortune 500company listed on the New York Stock Exchange under the symbol AFL. To findout more about Aflac, visit

About Children's Healthcare of Atlanta

Children's Healthcare of Atlanta, one of the leading pediatric healthcaresystems in the country, is a not-for-profit organization that benefits fromthe generous philanthropic and volunteer support of our community. Operatingthree hospitals with more than half a million patient visits annually,

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store